000 | 01467 a2200433 4500 | ||
---|---|---|---|
005 | 20250515043235.0 | ||
264 | 0 | _c20061108 | |
008 | 200611s 0 0 eng d | ||
022 | _a1526-632X | ||
024 | 7 |
_a10.1212/01.wnl.0000238401.76928.45 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPontone, Gregory | |
245 | 0 | 0 |
_aClinical features associated with impulse control disorders in Parkinson disease. _h[electronic resource] |
260 |
_bNeurology _cOct 2006 |
||
300 |
_a1258-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 |
_aDisruptive, Impulse Control, and Conduct Disorders _xdiagnosis |
650 | 0 | 4 |
_aDopamine Agonists _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aObsessive-Compulsive Disorder _xdiagnosis |
650 | 0 | 4 |
_aParkinson Disease _xdiagnosis |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 |
_aRisk Assessment _xmethods |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
700 | 1 | _aWilliams, James R | |
700 | 1 | _aBassett, Susan Spear | |
700 | 1 | _aMarsh, Laur | |
773 | 0 |
_tNeurology _gvol. 67 _gno. 7 _gp. 1258-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/01.wnl.0000238401.76928.45 _zAvailable from publisher's website |
999 |
_c16607371 _d16607371 |